Explore

Trendline Trendline
Palatin Technologies to List on Nasdaq, Enhancing Market Visibility

Palatin Technologies to List on Nasdaq, Enhancing Market Visibility

Palatin Technologies to List on Nasdaq, Enhancing Market Visibility
Trendline Trendline
Contineum Therapeutics Grants Stock Options to New Employee Under Nasdaq Rule

Contineum Therapeutics Grants Stock Options to New Employee Under Nasdaq Rule

Contineum Therapeutics Grants Stock Options to New Employee Under Nasdaq Rule
Trendline Trendline
Stoke Therapeutics Grants Stock Options to New Employees Under Nasdaq Rule

Stoke Therapeutics Grants Stock Options to New Employees Under Nasdaq Rule

Stoke Therapeutics Grants Stock Options to New Employees Under Nasdaq Rule
Trendline Trendline
Opening Bell: New York Stock Exchange and Nasdaq Begin Trading on May 18, 2026

Opening Bell: New York Stock Exchange and Nasdaq Begin Trading on May 18, 2026

Opening Bell: New York Stock Exchange and Nasdaq Begin Trading on May 18, 2026
Trendline Trendline
Cipher Mining Inc. Receives 'Moderate Buy' Consensus from Brokerages Amid Stock Performance

Cipher Mining Inc. Receives 'Moderate Buy' Consensus from Brokerages Amid Stock Performance

Cipher Mining Inc. Receives 'Moderate Buy' Consensus from Brokerages Amid Stock Performance
Trendline Trendline
SpaceX Plans Accelerated IPO to Raise $75 Billion, Targeting Nasdaq Debut

SpaceX Plans Accelerated IPO to Raise $75 Billion, Targeting Nasdaq Debut

SpaceX Plans Accelerated IPO to Raise $75 Billion, Targeting Nasdaq Debut
Trendline Trendline
SpaceX Accelerates IPO Plans, Aiming for Nasdaq Listing by June

SpaceX Accelerates IPO Plans, Aiming for Nasdaq Listing by June

SpaceX Accelerates IPO Plans, Aiming for Nasdaq Listing by June
Trendline Trendline
SpaceX Plans IPO with $1.75 Trillion Valuation, Aiming for June Launch

SpaceX Plans IPO with $1.75 Trillion Valuation, Aiming for June Launch

SpaceX Plans IPO with $1.75 Trillion Valuation, Aiming for June Launch
Trendline Trendline
Inmune Bio to Release Year-End 2025 Financial Results, Impacting Investor Sentiment

Inmune Bio to Release Year-End 2025 Financial Results, Impacting Investor Sentiment

Inmune Bio to Release Year-End 2025 Financial Results, Impacting Investor Sentiment
Trendline Trendline
Cerebras Prices IPO, Raises $5.55 Billion Amid AI Chip Interest

Cerebras Prices IPO, Raises $5.55 Billion Amid AI Chip Interest

Cerebras Prices IPO, Raises $5.55 Billion Amid AI Chip Interest
Trendline Trendline
Silexion Therapeutics Reports Increased Net Loss Amid R Expansion for SIL204

Silexion Therapeutics Reports Increased Net Loss Amid R Expansion for SIL204

Silexion Therapeutics Reports Increased Net Loss Amid R Expansion for SIL204
Trendline Trendline
SpaceX Plans Public IPO Filing, Aiming for Record Valuation

SpaceX Plans Public IPO Filing, Aiming for Record Valuation

SpaceX Plans Public IPO Filing, Aiming for Record Valuation